{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:13:34Z","timestamp":1787249614760,"version":"build-2736575974"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Methylene blue (MB) has been used to increase blood pressure in patients with septic shock by acting on guanylate cyclase and nitric oxide synthase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether the administration of MB to patients in the initial phase of septic shock leads to a reduction in the use of vasopressors compared to the Control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a 1:1 randomized clinical trial of two groups (MB and Control). Forty-two patients were included in the present study; 23 patients were allocated to the Control group, and 19 were randomized to the MB group. Both groups had access to standard treatment, consisting of fluid replacement, vasopressors, and antibiotic therapy. Patients received a loading dose of MB (3\u2009mg\/kg) and maintenance (0.5\u2009mg\/kg\/h) for 48\u2009h. Vasopressor doses, laboratory test results, inflammatory and anti-inflammatory cytokine levels, and hemodynamic monitoring were recorded before the infusion of MB (T1) and after 20\u2009min (T2), 2\u2009h (T3), 24\u2009h (T4), 48\u2009h after the infusion started (T5) and 24\u2009h after weaning (T6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MB therapy was started together with the indication of vasopressin (VAS) as a second vasopressor. The MB group showed an immediate reduction in NOR dosage, an earlier reduction in VAS dosage, and higher IL-10 levels compared to the Control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early administration of MB in combination with standard treatment for septic shock might be reduce vasopressors dose. Continuous infusion of MB for 48\u2009h was considered safe and there was no adverse events. These results highlight the potential of MB as a safe adjuvant therapeutic option in the treatment of septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/clinicaltrials.gov\/<\/jats:uri>\n                      , identifier RBR-96584w4.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1431321","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T09:40:51Z","timestamp":1728898851000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Methylene blue therapy in addition to standard treatment for acute-phase septic shock: a pilot randomized controlled trial"],"prefix":"10.3389","volume":"11","author":[{"given":"Fabio","family":"Luis-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra Gon\u00e7alves","family":"Menegueti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Moreira","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina dos Reis","family":"Sepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cec\u00edlia","family":"Jordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Mestriner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Cesar","family":"Petroski-Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Pedro","family":"Brito-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Artur","family":"Costa-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Lemos","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Derm\u00ednio","family":"Donadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Barizza","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Henrique Martins","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bellissimo-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Basile-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Becari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Roberto Barbosa","family":"Evora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Auxiliadora-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5935\/1678-9741.20140115","article-title":"Twenty years of vasoplegic syndrome treatment in heart surgery: methylene blue revised","volume":"30","author":"Evora","year":"2015","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"key":"ref4","first-page":"102","article-title":"Eficacia del azul de metileno como coadyuvante en el tratamiento de pacientes con choque s\u00e9ptico","volume":"30","author":"Arz\u00e1palo","year":"2016","journal-title":"Rev Asoc Mex Med Cirt Ter Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1014276","DOI":"10.3389\/fmed.2022.1014276","article-title":"Methylene blue dosing strategies in critically ill adults with shock-a retrospective cohort study","volume":"9","author":"Sari-Yavuz","year":"2022","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of Vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e32743","DOI":"10.1097\/MD.0000000000032743","article-title":"Effect of methylene blue on hemodynamic response in the early phase of septic shock: a case series","volume":"102","author":"Luis-Silva","year":"2023","journal-title":"Medicine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1007\/s12325-020-01422-x","article-title":"Vasopressor-sparing action of methylene blue in severe Sepsis and shock: a narrative review","volume":"37","author":"Puntillo","year":"2020","journal-title":"Adv Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/NPM-210824","article-title":"Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: a randomized controlled trial","volume":"15","author":"Ismail","year":"2022","journal-title":"J Neonatal Perinatal Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial","volume":"27","author":"Ibarra-Estrada","year":"2023","journal-title":"Crit Care"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e28599","DOI":"10.1097\/MD.0000000000028599","article-title":"Effect of methylene blue on hemodynamic and metabolic response in septic shock patients","volume":"101","author":"Luis-Silva","year":"2022","journal-title":"Medicine"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bcp.12763","article-title":"Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies","volume":"81","author":"Graudins","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1051\/ject\/200840206","article-title":"Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review","volume":"40","author":"McRobb","year":"2008","journal-title":"J Extra Corpor Technol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pneurobio.2011.10.007","article-title":"Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue","volume":"96","author":"Rojas","year":"2012","journal-title":"Prog Neurobiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"950596","DOI":"10.3389\/fmed.2022.950596","article-title":"Efficacy and safety of methylene blue in patients with vasodilatory shock: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.clinsp.2022.100139","article-title":"Methylene blue to neonatal septic shock treatment in neonate pigs","volume":"77","author":"Gon\u00e7alves-Ferri","year":"2022","journal-title":"Clinics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1366062","DOI":"10.3389\/fmed.2024.1366062","article-title":"Methylene blue in sepsis and septic shock: a systematic review and meta-analysis","volume":"11","author":"Ballarin","year":"2024","journal-title":"Front Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1590\/S0100-879X1999001200009","article-title":"Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue","volume":"32","author":"Weingartner","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bja\/aet116","article-title":"Performance of a new pulse contour method for continuous cardiac output monitoring: validation in critically ill patients","volume":"111","author":"Bendjelid","year":"2013","journal-title":"Br J Anaesth"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1172\/JCI1378","article-title":"Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism","volume":"101","author":"Dweik","year":"1998","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13054-024-04839-w","article-title":"Administration of methylene blue in septic shock: pros and cons","volume":"28","author":"Arias-Ortiz","year":"2024","journal-title":"Crit Care"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1431321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T09:40:55Z","timestamp":1728898855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1431321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":22,"alternative-id":["10.3389\/fmed.2024.1431321"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1431321","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"1431321"}}